Bank Of America Corp Pacira Bio Sciences, Inc. Transaction History
Bank Of America Corp
- $1.17 Trillion
- Q4 2024
A detailed history of Bank Of America Corp transactions in Pacira Bio Sciences, Inc. stock. As of the latest transaction made, Bank Of America Corp holds 137,197 shares of PCRX stock, worth $3.48 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
137,197
Previous 242,139
43.34%
Holding current value
$3.48 Million
Previous $3.65 Million
29.13%
% of portfolio
0.0%
Previous 0.0%
Shares
14 transactions
Others Institutions Holding PCRX
# of Institutions
260Shares Held
49.8MCall Options Held
1.03MPut Options Held
139K-
Black Rock Inc. New York, NY8.01MShares$203 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.26MShares$134 Million0.0% of portfolio
-
Pacer Advisors, Inc. Malvern, PA3.26MShares$82.8 Million0.15% of portfolio
-
D. E. Shaw & Co., Inc. New York, NY2.26MShares$57.3 Million0.03% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny1.99MShares$50.6 Million0.06% of portfolio
About Pacira BioSciences, Inc.
- Ticker PCRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 45,824,200
- Market Cap $1.16B
- Description
- Pacira BioSciences, Inc. provides non-opioid pain management and regenerative health solutions for healthcare practitioners and their patients in the United States. The company offers EXPAREL, a bupivacaine liposome injectable suspension; ZILRETTA, a triamcinolone acetonide extended-release injectable suspension; and iovera system, a non-opioid ...